Cypress Capital Management (Delaware)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,650
| Closed | -$215K | – | 202 |
|
|
2022
Q1 | $215K | Hold |
1,650
| – | – | 0.03% | 199 |
|
|
2021
Q4 | $252K | Hold |
1,650
| – | – | 0.03% | 193 |
|
|
2021
Q3 | $270K | Hold |
1,650
| – | – | 0.04% | 162 |
|
|
2021
Q2 | $270K | Hold |
1,650
| – | – | 0.04% | 162 |
|
|
2021
Q1 | $248K | Hold |
1,650
| – | – | 0.03% | 160 |
|
|
2020
Q4 | $250K | Hold |
1,650
| – | – | 0.03% | 162 |
|
|
2020
Q3 | $223K | Hold |
1,650
| – | – | 0.03% | 161 |
|
|
2020
Q2 | $226K | Buy |
+1,650
| New | +$226K | 0.04% | 156 |
|
|
2018
Q4 | – | Sell |
-1,650
| Closed | -$201K | – | 148 |
|
|
2018
Q3 | $201K | Buy |
+1,650
| New | +$201K | 0.04% | 149 |
|
|
2018
Q2 | – | Sell |
-1,950
| Closed | -$208K | – | 152 |
|
|
2018
Q1 | $208K | Hold |
1,950
| – | – | 0.04% | 139 |
|
|
2017
Q4 | $208K | Buy |
+1,950
| New | +$208K | 0.04% | 143 |
|